Medi-MIBI is for diagnostic use only. After radiolabelling with sodium pertechnetate (99mTc) solution, the solution of technetium (99mTc) sestamibi obtained is indicated for:

  • Myocardial perfusion scintigraphy

  • Assessment of global ventricular function

  • Scintimammography for the detection of suspected breast cancer

  • Localisation of hyperfunctioning parathyroid tissue

Danish Marketing Authorisation No.: DK. R. 2236

For more detailed information, such as the dosage of Medi-MIBI, please refer to the manufacturer's Fact Sheet and the Summary of Product Characteristics found below:

Fact Sheet

Summary of Product Characteristics for Medi-MIBI